By www.reliablemarketsize.com
Global Primary Biliary Cirrhosis Drug Market Research Report 2024 Story
92
$ 2900
Primary Biliary Cirrhosis Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AlbireoPharma CymaBay Therapeutics, Inc. Dr. Falk Pharma GmbH Enanta Pharmaceuticals, Inc. GlaxoSmithKline Plc Intercept Pharmaceuticals, Inc. Johnson & Johnson MediGene AG NGM Biopharmaceuticals, Inc. Virobay Inc.